Lantheus Holdings (LNTH) Change in Account Payables (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Change in Account Payables of $190000.0 for Q1 2026, down 96.19% year-over-year from $5.0 million in Q1 2025, and up 100.59% quarter-over-quarter from -$32.0 million in Q4 2025.
Lantheus Holdings (LNTH) Change in Account Payables (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Change in Account Payables for 13 consecutive years, with $190000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables fell 96.19% year-over-year to $190000.0; the TTM figure through Mar 2026 stood at -$7.3 million (down 1923.33% YoY), while the FY2025 annual figure was -$2.5 million, up 71.69% from the prior year.
- Change in Account Payables rose to $190000.0 in Q1 2026 per LNTH's latest filing, from -$32.0 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $20.1 million in Q3 2025 and bottomed at -$32.0 million in Q4 2025.
- Historically, Change in Account Payables has averaged $375529.4 across 5 years, with a median of $1.5 million in 2022.
- On a YoY basis, Change in Account Payables climbed as much as 933.63% in 2022 and fell as far as 1349.31% in 2022.
- Lantheus Holdings' Change in Account Payables stood at -$8.1 million in 2022, then surged by 162.15% to $5.0 million in 2023, then sank by 297.56% to -$10.0 million in 2024, then plunged by 221.09% to -$32.0 million in 2025, then soared by 100.59% to $190000.0 in 2026.
- Business Quant data shows LNTH's Change in Account Payables at $190000.0 in Q1 2026, -$32.0 million in Q4 2025, and $20.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Lantheus Holdings | 6.52 Bn | 5.93 Bn | 241.86 Mn | 1.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.39 Mn |
| Jun 30, 2026 | 1.39 Mn |
| Mar 31, 2026 | 190,000.00 |
| Mar 31, 2026 | 190,000.00 |
| Dec 31, 2025 | -31.97 Mn |
| Dec 31, 2025 | -31.97 Mn |
| Sep 30, 2025 | 20.11 Mn |
| Sep 30, 2025 | 20.11 Mn |
| Jun 30, 2025 | 4.38 Mn |
| Jun 30, 2025 | 4.38 Mn |
| Mar 31, 2025 | 4.98 Mn |
| Mar 31, 2025 | 4.98 Mn |
| Dec 31, 2024 | -9.96 Mn |
| Dec 31, 2024 | -9.96 Mn |
| Sep 30, 2024 | -5.72 Mn |
| Sep 30, 2024 | -5.72 Mn |
| Jun 30, 2024 | 10.34 Mn |
| Jun 30, 2024 | 10.34 Mn |
| Mar 31, 2024 | -3.46 Mn |
| Mar 31, 2024 | -3.46 Mn |